Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum RXi Pharmaceuticals Corp RXII

"RXi Pharmaceuticals Corp is a clinical-stage RNAi company developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which address significant unmet medical needs."

Bullboard (NDAQ:RXII)

View:
Post by coolfooldumbguyon Oct 01, 2018 10:53am

it's a buy today for me

getting onboard this one at these bargain prices,so glta.
Post by stargazer1on Jul 10, 2018 11:36pm

Price shooting upward on high volume

The stock price leveled out the last few days, and today, on a volume of over a million shares it basically went ballistic, going from $1.84 to $2.25. Possibly a press release in the works? Or not ...more  
Post by stargazer1on Jul 08, 2017 6:24pm

Possible announcement will send stock shooting upward

  RXII’s stock price and warrants started makin unprecedented moves upward Thursday. RXII usually trades a few thousand shares, but Thursday it traded around 200,000 shares, and Friday, over Two ...more  
Comment by SimArchitecton Feb 08, 2017 11:14pm

RE:RXIIW warrant selling at steep steep discount to true market

OMG! I thought I was crazy about those warrants! Thanks for sharing your analysis, I am also 100% bought in!
Post by RICHGUNon Feb 08, 2017 7:32pm

RXIIW warrant selling at steep steep discount to true market

The-stock is at $.73 and the warrants are trading at .169 Cents. The warrants are good until December 2021 and have a strike price of $.90. If you put them on the CBOE options calculator they come out ...more  
Post by craighenryon Aug 30, 2015 4:42pm

Could be an interesting week

If we get  IND news! Then. SCAR results hopefully in October. I bought in at .39 and .40 last week and week before. Fingers crossed!
Post by thefabergeggon Jun 10, 2015 6:32pm

just BTFD

getting a lot of institutional buying, LINK CNBC Coverage LINK
Post by mersoleil11on Jun 09, 2015 10:39am

They do deliver great news too

Tue, Jun 9, 2015, 10:37AM EDT : RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Novel RNAi Platform https://finance.yahoo.com/news/rxi-pharmaceuticals-strengthens ...more  
Comment by thefabergeggon Jun 08, 2015 6:39pm

RE:how come?

they have another 6m to go for delisting if stock is under $1, so stock will likely get run up here. 
Post by campston Jun 08, 2015 12:06pm

how come?

Deficiency of Nasdaq continued listing requirements.  No RS prior to PO.  What gives?
Post by thefabergeggon Jun 06, 2015 10:38am

Easy triple

Friend told me about this. Seems harmless here and could easily triple in short term, they need to get stock $1+ or get delisted  LOL. 
Post by mersoleil11on Jun 01, 2015 8:26am

Did you know that stock ? take a look, could be $$$$

NEWS today https://www.marketwired.com/press-release/rxi-pharmaceuticals-ceo-dr-geert-cauwenbergh-interviewed-by-the-life-sciences-report-nasdaq-rxii-2024961.htm Extract : "We own our self ...more  
Post by mersoleil11on May 11, 2015 2:53pm

Great news !

Do your DD about RNAI ... I did and I reload this fabulous stock at its year's bottom SP https://www.stockhouse.com/news/press-releases/2015/05/11/rxi-pharmaceuticals-presented-promising-new-data ...more  
Post by mersoleil11on May 06, 2015 8:35am

Price target 5 $

Analysts at HC Wainright lowered their price target on shares of RXi Pharmaceuticals Corp from $9.00 to $5.00 and set a buy rating on the stock in a research note on Tuesday, March 31st. They noted ...more  
Comment by campston Apr 17, 2015 9:16am

RE:Big News!

two analysts covering, one buy, one outperform. Could be a big chart reversal..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities